Neopharmaceutical

Neopharm Group of Companies is a Russian pharmacy chain in Russia. The Group of Companies includes two brands: Neopharm and Stolichki pharmacy chains, aimed at different target groups of buyers.

As of July 2018, there are more than 530 points of sale in the management of the Group of Companies, pharmacy formats such as hypermarkets and supermarkets of health and beauty products are actively developing.

History

2022: State Duma Deputy Yevgeny Nifantyev sold pharmacy assets

State Duma Deputy Yevgeny Nifantyev transferred the rights to 99.99% of Neo-Pharm LLC, which manages the Neopharm and Stolichki pharmacy chains, to the Zdravinvest closed mutual investment fund (ZPIF) under the management of Modern Real Estate Funds (formerly Sberbank Real Estate Funds). The deal was closed on July 1, 2022, according to data from the SPARK-Interfax system.

Another 0.01% of Neopharm LLC is still owned by Lydia Nifantieva, mother of Yevgeny Nifantiev, ex-general director of Neopharm pharmacy chains. By July 8, 2022, this position is held by Oleg Ivanushkin.

State Duma deputy Yevgeny Nifantyev sold pharmacy assets

The fact that Evgeny Nifantyev sold pharmacy assets was noticed. " Sheets The State Duma deputy confirmed to the publication that he no longer owns Neo-Pharm, and added that it "came under the control of several dozen shareholders who are not familiar with each other." He did not name their exact number and their names, specifying only that each of them owns from 1 to 10% of the total number of shares.

These are mainly people who have previously invested in real estate, - said Evgeny Nifantyev.

Experts interviewed by the publication estimated the market value of two pharmacy chains at 55-70 billion rubles. According to market participants, the sale of networks to a closed mutual fund will protect assets from secondary sanctions, so the deal to transfer rights to the company to the fund may be cash-strapped. Such funds are usually used, among other things, to conceal the ultimate beneficiaries. The lack of communication between shareholders will not allow them to unite and sell shares to each other, concentrating a controlling stake in the company in their hands, said Nikolai Bespalov, development director of the analytical company RNC Pharma.

On March 24, 2022, Yevgeny Nifantyev, like other 327 State Duma deputies, was included in the sanctions list of the US Treasury.

By July 2022, Neo-Farm has more than 1,000 pharmacies in 80 cities in the Central and North-Western districts.^[1]

2018: Online Sales Monitoring Pilot

The pharmaceutical manufacturer of Bosnia and Herzegovina "Bosnalek" and the Russian pharmacy chain "Neopharm" on July 25, 2018 signed an agreement on the provision of online cash registers in connection with the entry into force of the 54-FZ law on the use of cash registers. The transition to the updated reporting format in full will occur from the fourth quarter of 2018.

As noted, Bosnalek has begun to work out a mechanism for disclosing data from online pharmacy cash registers on the sale of its drugs together with its strategic partner, the Neopharm group of companies. For the entire retail market as a whole, this is another step towards ensuring transparency of the movement of goods in the chain from manufacturer to consumer, in addition to mandatory drug labeling, which will become mandatory for all manufacturers from the beginning of 2020.

According to Valentina Buchneva, head of the Bosnalek Eurasia business unit, the open relationship between drug manufacturers and pharmacy chains will make it possible to more accurately plan production processes, assess product stocks on pharmacy shelves and make adjustments to supply schedules, ensuring uninterrupted supply of medicines to the population. In addition, the disclosure of sales information according to online cash registers demonstrates the readiness of the pharmacy chain to interact with reliable partners - drug manufacturers.

Mutual interest in maximum transparency in doing business has become the basis of this pilot project between the two companies. Neopharm is one of the few pharmacy chains technically ready to open online cash registers without transferring any personal data of the buyer, and the first network that will test this mechanism in practice thanks to a partnership with Bosnalek, - said the founder of the Neopharm pharmacy chain Yevgeny Nifantyev.

Notes

Шаблон:Remarks